Sungrae Kim

8PUBLICATIONS
25CO-AUTHORS
Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMajor global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 05, 2025
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

Sangmo Hong, Won J Kim, Sungrae Kim

|Jul 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Eun-Gyoung Hong, Kyung-Wan Min, SungWan Chun

|Dec 20, 2024
Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study).

Sangmo Hong, Won Jun Kim, Eun Seok Kang

|Mar 01, 2024
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.

Soo Lim, Seung-Hwan Lee, Kyung-Wan Min

|Jul 11, 2023
Association of Blood Pressure With Cardio-Renal Events and Mortality in Type 2 DM: A National Health Insurance Database.

Bo-Yeon Kim, Ji-In Lee, Hye-Mi Lee

|Nov 23, 2022
Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study.

Sang-Yong Kim, Sungrae Kim

Pageof 2

Frequent Collaborators

3 joint publications

Chang Beom Lee

2 joint publications

Dae Jung Kim

2 joint publications

Eun Seok Kang

1 joint publications

Sang-Yong Kim